We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
Learn about the common and serious side effects of Livdelzi (adalimumab-adaz), a biosimilar medication. Understand when to seek medical attention, how to manage potential reactions, and important precautions for safe treatment.
Welcome to Doctar's comprehensive guide on Livdelzi side effects. If you or a loved one are considering or currently using Livdelzi (adalimumab-adaz), a biosimilar to Humira, understanding its potential side effects is crucial for safe and effective treatment. This article aims to provide detailed, factual information about what to expect, how to manage common reactions, and when to seek immediate medical attention.
Livdelzi (adalimumab-adaz) is a biologic medication that belongs to a class of drugs called tumor necrosis factor (TNF) blockers. It is approved to treat various autoimmune conditions, including:
As a biosimilar, Livdelzi is highly similar to Humira (adalimumab), with no clinically meaningful differences in terms of safety, purity, and potency. It works by blocking TNF-alpha, a protein in the body that can cause inflammation and lead to the symptoms of these autoimmune diseases.
Like all medications, Livdelzi can cause side effects. These can range from mild and temporary to severe and potentially life-threatening. It's important to remember that not everyone experiences side effects, and their severity can vary greatly from person to person. Always discuss any concerns you have with your healthcare provider.
Many people using Livdelzi experience mild side effects, especially during the initial stages of treatment. These are often manageable and tend to lessen over time. Common side effects include:
While less common, some side effects of Livdelzi can be serious and require immediate medical attention. It's vital to be aware of these potential risks and know when to seek help.
Livdelzi works by suppressing the immune system, which can increase your risk of developing serious infections. These infections can be bacterial, viral, fungal, or parasitic, and may spread throughout the body. Examples include:
Symptoms of a serious infection include:
If you experience any of these symptoms, contact your doctor immediately.
Some individuals may experience an allergic reaction to Livdelzi. These reactions can range from mild to severe.Symptoms of a severe allergic reaction (anaphylaxis) include:
If you experience any signs of a severe allergic reaction, seek emergency medical care immediately.
TNF blockers like Livdelzi have been associated with new or worsening neurological conditions, including demyelinating diseases such as multiple sclerosis (MS) and optic neuritis.Symptoms to watch for include:
Report any new or worsening neurological symptoms to your doctor promptly.
Livdelzi can cause new or worsen existing heart failure. It should be used with caution in patients with heart failure.Symptoms of worsening heart failure include:
If you notice these symptoms, contact your doctor right away.
Rarely, Livdelzi can affect blood cell production, leading to serious blood disorders such as aplastic anemia, pancytopenia (low red blood cells, white blood cells, and platelets), leukopenia (low white blood cells), or thrombocytopenia (low platelets).Symptoms of blood problems include:
If you experience these symptoms, contact your doctor immediately.
Although rare, Livdelzi can cause severe liver injury, including liver failure.Symptoms of liver problems include:
Report any signs of liver problems to your doctor without delay.
An increased risk of certain cancers has been reported in patients taking TNF blockers, including lymphomas and other malignancies. This risk may be higher in children and young adults.Symptoms of cancer can vary but may include:
Discuss any concerns about cancer risk with your doctor.
Some patients may develop a lupus-like syndrome while taking Livdelzi.Symptoms include:
If these symptoms appear, inform your healthcare provider.
It's crucial to maintain open communication with your healthcare team while on Livdelzi. You should contact your doctor immediately or seek emergency medical care if you experience any of the following:
Even for mild side effects, if they are persistent, bothersome, or worsen, you should consult your doctor or pharmacist.
Before starting Livdelzi, your doctor will conduct a thorough evaluation to assess your risk factors. It's essential to inform your healthcare provider about your complete medical history, especially if you have:
Never stop taking Livdelzi or change your dosage without consulting your doctor.
Livdelzi can interact with other medications, potentially increasing the risk of side effects or reducing its effectiveness. Key interactions include:
Always provide your doctor and pharmacist with a complete list of all medications you are taking, including prescription drugs, over-the-counter medicines, vitamins, and herbal supplements.
A: Livdelzi is a biosimilar to Humira (adalimumab). Biosimilars are highly similar to their reference product (Humira) and are expected to have no clinically meaningful differences in terms of safety and effectiveness. Therefore, the side effect profile of Livdelzi is expected to be very similar to that of Humira.
A: Injection site reactions are usually mild and temporary, typically resolving within a few days (24-48 hours) after the injection. If they are severe, persist, or worsen, you should contact your doctor.
A: Hair loss is not listed as a common or widely reported side effect for adalimumab (the active ingredient in Livdelzi). However, some autoimmune conditions treated by Livdelzi can themselves cause hair loss. If you experience hair loss, discuss it with your doctor to determine the cause.
A: If you miss a dose, contact your healthcare provider or pharmacist for advice. They will provide specific instructions based on your treatment schedule and condition. Do not double your dose to make up for a missed one.
Livdelzi (adalimumab-adaz) is an effective treatment for various autoimmune conditions, but like all powerful medications, it comes with potential side effects. While many individuals experience only mild, manageable reactions, it's crucial to be aware of the signs of more serious complications, particularly infections and allergic reactions. Open communication with your healthcare provider is paramount. By understanding the risks and knowing when to seek medical attention, you can work together with your doctor to ensure the safest and most effective treatment journey possible.
The information provided in this article is based on publicly available drug information from regulatory bodies and medical resources, including the prescribing information for adalimumab-adaz and general knowledge of TNF inhibitors. Always consult with a qualified healthcare professional for personalized medical advice and treatment plans.
- U.S. Food and Drug Administration (FDA)
- National Institutes of Health (NIH) - MedlinePlus
- Prescribing information for adalimumab biosimilars

Sleeping tablets can help manage insomnia and sleep disorders when used correctly. This guide explains types, benefits, risks, and safe usage tips for better sleep health.
April 11, 2026
Explore the short-term and long-term effects of Adderall on the brain, including its uses, side effects, risks of misuse, and the importance of medical supervision for safe and effective treatment.
April 1, 2026

Curious if Pepto-Bismol can help your stomach after drinking? We explore the potential risks and what the research says about mixing Pepto-Bismol and alcohol, plus safer alternatives for hangover relief.
April 1, 2026